-
Actelion Seeks Expanded Approval for Opsumit to Treat CTEPH in EU
Actelion announced it has submitted a request to the European Medicines Agency to expand the approval for Opsumit for the treatment of inoperable CTEPH.
Click here to read more about this request.
What are your thoughts on this news?
Sorry, there were no replies found.
Log in to reply.